WuXi Healthcare Ventures
40
40M
26
3.08
3
0.35
8
- Stages of investment
- Areas of investment
Summary
The main department of described VC is located in the Cambridge. The fund was located in North America if to be more exact in United States.
The important activity for fund was in 2016. Despite it in 2019 the fund had an activity. The fund is generally included in 2-6 deals every year. Opposing the other organizations, this WuXi Healthcare Ventures works on 15 percentage points less the average amount of lead investments. The real fund results show that this VC is 2 percentage points less often commits exit comparing to other companies. When the investment is from WuXi Healthcare Ventures the average startup value is 500 millions - 1 billion dollars. The increased amount of exits for fund were in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars.
The overall number of key employees were 2.
The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. We can highlight the next thriving fund investment areas, such as Medical, Genetics. Among the most popular portfolio startups of the fund, we may highlight 23andMe, CStone Pharmaceuticals, Hua Medicine. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the WuXi Healthcare Ventures, startups are often financed by ARCH Venture Partners, Avalon Ventures, Torrey Pines Investment. The meaningful sponsors for the fund in investment in the same round are F-Prime Capital, ARCH Venture Partners, Canaan Partners. In the next rounds fund is usually obtained by Venrock, ARCH Venture Partners, 6 Dimensions Capital.
Investments analytics
Analytics
- Total investments
- 40
- Lead investments
- 3
- Exits
- 8
- Rounds per year
- 3.08
- Follow on index
- 0.35
- Investments by industry
- Biotechnology (35)
- Health Care (21)
- Medical (15)
- Therapeutics (14)
- Pharmaceutical (13) Show 16 more
- Investments by region
-
- United States (26)
- China (13)
- Israel (1)
- Peak activity year
- 2016
- Number of Unicorns
- 2
- Number of Decacorns
- 2
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 203M
- Group Appearance index
- 0.97
- Avg. company exit year
- 7
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Kollabo | 21 Sep 2021 | Human Resources, Recruiting, SaaS, Marketing, Service Industry, Staffing Agency | Seed | 2M | Zürich, Switzerland, Zurich |
Siku Lifang | 11 Mar 2021 | Software, Enterprise, SaaS | Early Stage Venture | 15M | Beijing, Dongcheng District, China |
UNITY Biotechnology | 19 Mar 2018 | Biotechnology, Health Care, Medical | Late Stage Venture | 55M | United States, California |
Zenas BioPharma | 23 Mar 2021 | Health Care, Pharmaceutical, Biopharma | Early Stage Venture |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.